Additionally, no consistency was found in changes in plasma Aβ1-40 levels between studies using APP/PS1, 3xTg-AD, or APPPS1 mice, and no consistency was found in plasma Aβ1-42 levels between studies using APP/PS1 and 3xTg-AD transgenic mice. This evidence concerns the gene PSEN1 and Alzheimer disease.